Clinical trial
Kinetic Biomarker for Chronic Lymphocytic Leukemia Prognosis
NCT00481858 · KineMed, Industry · Completed
Key facts
| NCT number | NCT00481858 |
|---|---|
| Title | Kinetic Biomarker for Chronic Lymphocytic Leukemia Prognosis |
| Official title | A CLL Research Consortium (CRC) Phase II Study of Kinetic Biomarker for Chronic Lymphocytic Leukemia (CLL) Prognosis |
| Acronym | CRC011 |
| Lead sponsor | KineMed, Industry |
| Collaborators | Chronic Lymphocytic Leukemia Research Consortium |
| Status | Completed |
| Study type | Observational |
| Conditions | Chronic Lymphocytic Leukemia |
| Enrollment | 150 |
| Start date | Jul 1, 2005 |
| Primary completion | Jul 1, 2010 |
| Completion | Jan 1, 2011 |
| First posted | Jun 4, 2007 |
| Last update posted | Feb 28, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: